| 生物活性 |
Ozuriftamab vedotin (BA3021), an antibody-drug conjugate (ADC), is a conditionally active biologic (CAB) anti-receptor tyrosine kinase orphan receptor 2 (ROR2) humanized monoclonal antibody Ozuriftamab conjugated to VcMMAE . Ozuriftamab vedotin has antitumor activities.
|